Gleevec Buyers Ask For Time To Mull 1st Circ. Rehearing Bid
Buyers of the leukemia drug Gleevec asked the First Circuit on Friday for more time to mull a rehearing bid after the court affirmed the dismissal of a proposed class action...To view the full article, register now.
Already a subscriber? Click here to view full article